Embecta Corp.

Embecta Corp. is a global medical device company focused on providing solutions for people living with diabetes. The company's products are used by over 30 million people in more than 100 countries for insulin administration and daily diabetes management. Embecta offers a broad portfolio of marketed products, including various pen needles, syringes, and safety injection devices. Its conventional pen needles are sterile, single-use medical devices designed for use with pen injectors for insulin or other diabetes medications. The company also sells safety pen needles, which feature shields that automatically deploy after injection to prevent needlestick exposure and injury. Both conventional and safety pen needles are compatible with widely available pen injectors. In addition to pen needles, Embecta sells sterile, single-use insulin syringes for injecting insulin drawn from vials. It also provides safety insulin syringes, which have a sliding safety arm that can be activated with one hand post-injection to protect healthcare workers from needlestick injuries. Embecta also promotes advances in diabetes care through engagement with the diabetes community, healthcare providers, and other stakeholders.